📰 Highest Dose News
Highest Dose News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Highest Dose. Real-time updates on events, politics, business and more.
November 13, 2023
A phase 1 randomized, controlled trial tested the safety of a toothpaste that was specially formulated to be used as oral immunotherapy by adults with peanut allergy.
April 26, 2023
- Single Doses of ALN-APP Demonstrated Dose-Dependent, Rapid and Sustained Reduction of sAPPα and sAPPβ in Cerebrospinal Fluid, with Up to 90% at Highest Dose to Date - - Encouraging... | April 26, 2023
April 26, 2023
Single Doses of ALN-APP Demonstrated Dose-Dependent, Rapid and Sustained Reduction of sAPPa and sAPPß in Cerebrospinal Fluid, with Up to 90% at Highest Dose to Date Encouraging Clinical Safety and
March 18, 2023
Results for TAK-279 (Formerly NDI-034858) Show a Significantly Greater Proportion of Patients Achieved Psoriasis Area and Severity Index (PASI) 75 at Doses ≥5mg at 12 Weeks1At the Highest Dose of TAK-279, 46% of Patients Achieved PASI 90 and 33% Achieved PASI 100 at 12 Weeks, Indicating a Near-Total or Total Clearan...